US Stock MarketDetailed Quotes

Plus Therapeutics (PSTV)

Watchlist

5.250
-0.510-8.85%

Close May 15 15:59 ET

5.320
+0.070+1.33%

Post 20:01 ET

36.03MMarket Cap-0.72P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Plus Therapeutics (PSTV) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-96.84%-20.78M

-416.68%-6.26M

30.76%-2.55M

-404.17%-5.8M

-36.76%-6.17M

17.87%-10.55M

35.62%-1.21M

-53.40%-3.68M

58.60%-1.15M

22.10%-4.51M

Net income from continuing operations

-72.49%-22.39M

-46.37%-5.71M

-53.90%-4.42M

275.20%5.15M

-433.61%-17.4M

2.54%-12.98M

-2.44%-3.9M

10.72%-2.87M

-98.38%-2.94M

32.13%-3.26M

Operating gains losses

146.25%2.62M

--0

---6.51M

--9.13M

-282,800.00%-5.65M

--0

---960K

----

Depreciation and amortization

-48.97%445K

-63.49%92K

-62.93%86K

-48.07%121K

-5.81%146K

38.85%872K

287.69%252K

23.40%232K

23.94%233K

-17.11%155K

Other non cash items

-13.65%3.06M

--0

-105.26%-185K

6,806.38%3.25M

828.01%3.55M

-113.61%-20K

--0

6,537.74%3.52M

-28.79%47K

Change In working capital

-287.49%-6.04M

-157.27%-1.36M

907.05%1.26M

-272.79%-4.5M

10.18%-1.44M

388.71%3.22M

50.57%2.37M

-142.39%-156K

255.40%2.61M

-15.76%-1.6M

-Change in receivables

143.61%249K

----

---1.02M

--571K

---571K

-727.47%-571K

--0

-Change in payables and accrued expense

-219.52%-5.62M

-79.62%688K

-216.67%-1.13M

-785.61%-2.76M

-5,523.26%-2.42M

227.88%4.7M

779.17%3.38M

304.66%966K

706.00%403K

98.82%-43K

-Change in other current assets

-450.00%-763K

-187.65%-1.4M

143.90%900K

-283.24%-339K

-50.67%74K

-90.91%218K

38.71%-486K

-78.04%369K

114.44%185K

-94.63%150K

-Change in other current liabilities

171.54%93K

545.45%147K

73.53%-9K

68.75%-10K

-12.90%-35K

-11.11%-130K

-10.00%-33K

-9.68%-34K

-18.52%-32K

-6.90%-31K

-Change in other working capital

----

122.06%370K

-454.80%-997K

-95.48%87K

---1.46M

280.30%2.05M

-231.42%-1.68M

Cash from discontinued investing activities

Operating cash flow

-96.84%-20.78M

-416.68%-6.26M

30.76%-2.55M

-404.17%-5.8M

-36.76%-6.17M

17.87%-10.55M

35.62%-1.21M

-53.40%-3.68M

58.60%-1.15M

22.10%-4.51M

Investing cash flow

Cash flow from continuing investing activities

79.23%-854K

-1,782.81%-1.08M

14,511.11%1.3M

-21.83%-4.63M

1,077.47%3.56M

-2,469.38%-4.11M

252.38%64K

10.00%-9K

-34,463.64%-3.8M

-275.26%-364K

Net PPE purchase and sale

74.66%-37K

-172.73%-30K

-92.86%-27K

91.36%-7K

167.50%27K

8.75%-146K

73.81%-11K

-40.00%-14K

-636.36%-81K

58.76%-40K

Net intangibles purchase and sale

--0

--7K

---7K

----

---545K

--0

----

Net investment purchase and sale

76.11%-817K

-1,505.33%-1.05M

26,520.00%1.33M

-45.62%-4.63M

1,189.81%3.53M

---3.42M

--75K

--5K

---3.18M

---324K

Cash from discontinued investing activities

Investing cash flow

79.23%-854K

-1,782.81%-1.08M

14,511.11%1.3M

-21.83%-4.63M

1,077.47%3.56M

-2,469.38%-4.11M

252.38%64K

10.00%-9K

-34,463.64%-3.8M

-275.26%-364K

Financing cash flow

Cash flow from continuing financing activities

389.91%30.31M

2.8M

12.31M

-59.84%2.8M

1,698.58%12.41M

79.59%6.19M

624.56%6.96M

-257.40%-776K

Net issuance payments of debt

-256.11%-2.51M

--750K

--0

-710.20%-3.26M

56.22%-704K

--0

24.88%-302K

0.00%-402K

Net common stock issuance

459.29%38.54M

--3M

39,528.89%17.74M

143.45%17.8M

--0

27.59%6.89M

--0

-101.54%-45K

436.32%7.31M

-141.79%-374K

Proceeds from stock option exercised by employees

----

---14.78M

--15.66M

----

--0

Net other financing activities

---5.72M

---949K

---4.55M

----

2,966.42%11.52M

----

---402K

Cash from discontinued financing activities

Financing cash flow

389.91%30.31M

--2.8M

--12.31M

-59.84%2.8M

1,698.58%12.41M

79.59%6.19M

--0

624.56%6.96M

-257.40%-776K

Net cash flow

Beginning cash position

-99.11%76K

986.59%13.29M

-54.54%2.23M

240.12%9.87M

-99.11%76K

-52.79%8.55M

-88.89%1.22M

-54.92%4.91M

-77.20%2.9M

-52.79%8.55M

Current changes in cash

202.41%8.68M

-295.03%-4.53M

399.70%11.06M

-479.61%-7.63M

273.20%9.79M

11.37%-8.48M

53.22%-1.15M

-3,423.42%-3.69M

210.01%2.01M

-4.74%-5.65M

End cash Position

11,423.68%8.76M

986.59%13.29M

-54.54%2.23M

240.12%9.87M

-99.11%76K

-88.89%1.22M

-54.92%4.91M

-77.20%2.9M

Free cash flow

-85.34%-20.84M

-413.91%-6.28M

30.10%-2.58M

-226.86%-5.81M

-35.62%-6.18M

13.57%-11.25M

36.45%-1.22M

-53.34%-3.69M

36.32%-1.78M

22.70%-4.55M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-96.84%-20.78M	-416.68%-6.26M	30.76%-2.55M	-404.17%-5.8M	-36.76%-6.17M	17.87%-10.55M	35.62%-1.21M	-53.40%-3.68M	58.60%-1.15M	22.10%-4.51M
Net income from continuing operations	-72.49%-22.39M	-46.37%-5.71M	-53.90%-4.42M	275.20%5.15M	-433.61%-17.4M	2.54%-12.98M	-2.44%-3.9M	10.72%-2.87M	-98.38%-2.94M	32.13%-3.26M
Operating gains losses	146.25%2.62M	--0	--0	---6.51M	--9.13M	-282,800.00%-5.65M	--0	---960K	----	----
Depreciation and amortization	-48.97%445K	-63.49%92K	-62.93%86K	-48.07%121K	-5.81%146K	38.85%872K	287.69%252K	23.40%232K	23.94%233K	-17.11%155K
Other non cash items	-13.65%3.06M	--0	--0	-105.26%-185K	6,806.38%3.25M	828.01%3.55M	-113.61%-20K	--0	6,537.74%3.52M	-28.79%47K
Change In working capital	-287.49%-6.04M	-157.27%-1.36M	907.05%1.26M	-272.79%-4.5M	10.18%-1.44M	388.71%3.22M	50.57%2.37M	-142.39%-156K	255.40%2.61M	-15.76%-1.6M
-Change in receivables	143.61%249K	----	----	---1.02M	--571K	---571K	-727.47%-571K	--0	--0	--0
-Change in payables and accrued expense	-219.52%-5.62M	-79.62%688K	-216.67%-1.13M	-785.61%-2.76M	-5,523.26%-2.42M	227.88%4.7M	779.17%3.38M	304.66%966K	706.00%403K	98.82%-43K
-Change in other current assets	-450.00%-763K	-187.65%-1.4M	143.90%900K	-283.24%-339K	-50.67%74K	-90.91%218K	38.71%-486K	-78.04%369K	114.44%185K	-94.63%150K
-Change in other current liabilities	171.54%93K	545.45%147K	73.53%-9K	68.75%-10K	-12.90%-35K	-11.11%-130K	-10.00%-33K	-9.68%-34K	-18.52%-32K	-6.90%-31K
-Change in other working capital	----	----	----	----	122.06%370K	-454.80%-997K	-95.48%87K	---1.46M	280.30%2.05M	-231.42%-1.68M
Cash from discontinued investing activities
Operating cash flow	-96.84%-20.78M	-416.68%-6.26M	30.76%-2.55M	-404.17%-5.8M	-36.76%-6.17M	17.87%-10.55M	35.62%-1.21M	-53.40%-3.68M	58.60%-1.15M	22.10%-4.51M
Investing cash flow
Cash flow from continuing investing activities	79.23%-854K	-1,782.81%-1.08M	14,511.11%1.3M	-21.83%-4.63M	1,077.47%3.56M	-2,469.38%-4.11M	252.38%64K	10.00%-9K	-34,463.64%-3.8M	-275.26%-364K
Net PPE purchase and sale	74.66%-37K	-172.73%-30K	-92.86%-27K	91.36%-7K	167.50%27K	8.75%-146K	73.81%-11K	-40.00%-14K	-636.36%-81K	58.76%-40K
Net intangibles purchase and sale	--0	--7K	---7K	----	----	---545K	--0	--0	----	----
Net investment purchase and sale	76.11%-817K	-1,505.33%-1.05M	26,520.00%1.33M	-45.62%-4.63M	1,189.81%3.53M	---3.42M	--75K	--5K	---3.18M	---324K
Cash from discontinued investing activities
Investing cash flow	79.23%-854K	-1,782.81%-1.08M	14,511.11%1.3M	-21.83%-4.63M	1,077.47%3.56M	-2,469.38%-4.11M	252.38%64K	10.00%-9K	-34,463.64%-3.8M	-275.26%-364K
Financing cash flow
Cash flow from continuing financing activities	389.91%30.31M	2.8M	12.31M	-59.84%2.8M	1,698.58%12.41M	79.59%6.19M	0	0	624.56%6.96M	-257.40%-776K
Net issuance payments of debt	-256.11%-2.51M	--750K	--0	--0	-710.20%-3.26M	56.22%-704K	--0	--0	24.88%-302K	0.00%-402K
Net common stock issuance	459.29%38.54M	--3M	39,528.89%17.74M	143.45%17.8M	--0	27.59%6.89M	--0	-101.54%-45K	436.32%7.31M	-141.79%-374K
Proceeds from stock option exercised by employees	----	----	----	---14.78M	--15.66M	----	----	----	--0	--0
Net other financing activities	---5.72M	---949K	---4.55M	----	2,966.42%11.52M	----	----	----	----	---402K
Cash from discontinued financing activities
Financing cash flow	389.91%30.31M	--2.8M	--12.31M	-59.84%2.8M	1,698.58%12.41M	79.59%6.19M	--0	--0	624.56%6.96M	-257.40%-776K
Net cash flow
Beginning cash position	-99.11%76K	986.59%13.29M	-54.54%2.23M	240.12%9.87M	-99.11%76K	-52.79%8.55M	-88.89%1.22M	-54.92%4.91M	-77.20%2.9M	-52.79%8.55M
Current changes in cash	202.41%8.68M	-295.03%-4.53M	399.70%11.06M	-479.61%-7.63M	273.20%9.79M	11.37%-8.48M	53.22%-1.15M	-3,423.42%-3.69M	210.01%2.01M	-4.74%-5.65M
End cash Position	11,423.68%8.76M	11,423.68%8.76M	986.59%13.29M	-54.54%2.23M	240.12%9.87M	-99.11%76K	-99.11%76K	-88.89%1.22M	-54.92%4.91M	-77.20%2.9M
Free cash flow	-85.34%-20.84M	-413.91%-6.28M	30.10%-2.58M	-226.86%-5.81M	-35.62%-6.18M	13.57%-11.25M	36.45%-1.22M	-53.34%-3.69M	36.32%-1.78M	22.70%-4.55M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm